Breast Lobular Carcinoma In Situ
11 clinical trials · Condition
◉ Watch Breast Lobular Carcinoma In Situ
| Record | Firm | Date |
|---|---|---|
| Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk (NCT04570956) | Mayo Clinic | 2021-07-26 |
| EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer (NCT05086705) | Ohio State University Comprehensive Cancer Center | 2020-10-07 |
| Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer (NCT03979508) | Mayo Clinic | 2020-01-10 |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery (NCT03317405) | National Cancer Institute (NCI) | 2018-10-31 |
| Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer (NCT03323658) | National Cancer Institute (NCI) | 2018-06-15 |
Track Breast Lobular Carcinoma In Situ automatically
Every clearance here is in the API, with alerts when new ones post.